Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis

NCT03432260

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +7 more
Locations
  • DURECT Study Site 0001 San Diego, California, United States
  • DURECT Study Site 007 Miami, Florida, United States
  • DURECT Study Site 0004 Atlanta, Georgia, United States
  • DURECT Study Site 0002 Chicago, Illinois, United States
View Trial Details
Completed

Study of Safety and Tolerability of DCR HBVS

NCT03772249

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Monash Health Clayton, Victoria, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • Queen Mary Hospital (The University of Hong Kong) Hong Kong
  • Clinical Site Auckland, New Zealand
View Trial Details
Completed

A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment

NCT04563026

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +7 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Southern California Research Center Coronado, California, United States
  • Keck Hospital of University of Southern California (USC) Los Angeles, California, United States
View all 68 locations
View Trial Details
Completed

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

NCT04535037

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations
  • GSK Investigational Site Rosenheim, Bavaria, Germany
  • GSK Investigational Site Schönau am Königssee, Bavaria, Germany
  • GSK Investigational Site Leipzig, Brandenburg, Germany
  • GSK Investigational Site Wolfsburg, Lower Saxony, Germany
View all 20 locations
View Trial Details

Related conditions